News ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
93.00 ^USD	+16.13%		-38.24%	-48.96%

02-12	Sector Update: Health Care Stocks Higher Thursday Afternoon	MT
02-12	Top Midday Decliners	MT

All News

02-13	ICON PUBLIC LIMITED COMPANY Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud	BU
02-13	Securities Fraud Investigation Into ICON Public Limited Company (ICLR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm	BU
02-13	ICON Public Limited Company (ICLR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation	BU
02-13	ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues - Hagens Berman	PR
02-12	Securities Fraud Investigation Into ICON Public Limited Company (ICLR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz	BU
02-12	Ademi LLP Investigates Claims of Securities Fraud against ICON plc	PR
02-12	Sector Update: Health Care Stocks Higher Thursday Afternoon	MT
02-12	Top Midday Decliners	MT
02-12	Top Midday Stories: ICON Launches Internal Probe Into Accounting Practices; AppLovin Shares Fall Despite Strong Q4 Earnings, Guidance	MT
02-12	Rosen Law Firm Encourages ICON plc Investors to Inquire About Securities Class Action Investigation – ICLR	BU
02-12	ICON Shares Slump Amid Internal Investigation	MT
02-12	Top Premarket Decliners	MT
02-12	ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices	BU
01-27	ICON?s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership	CI
01-27	ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership	BU
01-08	Peace Was Cheaper
01-08	Truist Downgrades ICON PLC to Hold From Buy, Trims Price Target to $222 From $231	MT
01-08	Analyst recommendations: Alphabet, Chubb, Ford, Stellantis, The Gap…
12-15	BofA Securities Downgrades ICON to Neutral From Buy	MT
12-09	ICON plc Releases Findings from Two Biotech Sector Survey	CI
12-09	ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive	BU
12-02	Icon survey reveals increasing clinical trial startup delays	RE
12-02	Icon plc Announces Results of Its Latest Industry Survey	CI
12-02	ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions	BU
11-20	ICON Public Limited Company Presents at Jefferies London Healthcare Conference 2025, Nov-19-2025 09:00 AM

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

News ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

All News

Filters